Canada Life’s XBiotech XBIT Stock Holding History

Canada Life’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-635	Closed	-$6K	–	2469
2022 Q1	$6K	Hold	635	–	–	﹤0.01%	2464
2021 Q4	$7K	Hold	635	–	–	﹤0.01%	2465
2021 Q3	$8K	Hold	635	–	–	﹤0.01%	2514
2021 Q2	$10K	Hold	635	–	–	﹤0.01%	2538
2021 Q1	$11K	Sell	635 -1,863	-75%	-$34.8K	﹤0.01%	2556
2020 Q4	$39K	Hold	2,498	–	–	﹤0.01%	2371
2020 Q3	$48K	Hold	2,498	–	–	﹤0.01%	2189
2020 Q2	$34K	Buy	+2,498	New	+$35.1K	﹤0.01%	2363
2017 Q4	–	Sell	-2,000	Closed	-$9K	–	2563
2017 Q3	$9K	Hold	2,000	–	–	﹤0.01%	2526
2017 Q2	$9K	Hold	2,000	–	–	﹤0.01%	2535
2017 Q1	$33K	Hold	2,000	–	–	﹤0.01%	2392
2016 Q4	$20K	Hold	2,000	–	–	﹤0.01%	2493
2016 Q3	$27K	Hold	2,000	–	–	﹤0.01%	2444
2016 Q2	$42K	Buy	+2,000	New	+$28.9K	﹤0.01%	2351

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Canada Life's XBIT Position: Q2 2022 in Review

Canada Life sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 635 shares — an estimated $6K sold.

Canada Life first reported a position in XBIT in Q2 2016 and held it in 14 quarters. The position peaked at $48K in Q3 2020. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

Canada Life reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
Canada Life sold 635 XBiotech shares in Q2 2022, an estimated $6K.
Canada Life first reported a position in XBiotech in Q2 2016 and held it in 14 quarters.
Canada Life's XBiotech position peaked at $48K in Q3 2020.
56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.